Loading...
Price Table
* Prices are based on daily market changes.
DateOpenHighLowCloseVolumeDelivery %20-Day sma50-Day sma200-Day sma
Day High Low Range
TimeLowesthighestVolume
Past Performance & Moving Averages
Day’sLow high rangeSMAStock performanceNifty performance
PIVOT POINTS
NAMES4S3S2S1PIVOT POINTSR1R2R3R4
CLASSIC---------
WOODIE‘S----
FIBONACCI--
CAMARILLA-
Trend Analysis
Key Data
Market capBook valuestock p/eDividend yieldroceroesales growth (3Y)face value (3Y)
Profile

Glaxosmithkline Pharmaceuticals Ltd.

GlaxoSmithKline Pharmaceuticals Ltd. or GSK Rx India was established in 1924 in India. It is one of the oldest pharmaceutical companies and employs over 3,500 people. Globally, the company is around £28.4 billion, and it is leading research-based healthcare and pharmaceutical companies. In India, it is one of the market leaders with an approximate turnover of INR 2080 crore and a share of 5.1%. The Company is also one of the world's leading research-based pharmaceutical and healthcare companies. It is committed to enhancing the quality of human life by enabling people to do more, feel better, and live longer. The company leads in many therapeutic segments such as dermatology, anti–hermeneutics, and hormones. It has 7 products in the top 50 brands, and the top five GSK products are Augmentin, Calpol, Ceftum, Phexin, and Betnesol. The company's vaccines division is ranked first in a fast-growing vaccines market. Some leading products in India are Havrix, Varilrix, Rotarix, Hiberix, and Cervarix. GSK India's R&D centers at Thane and Nashik have been granted recognition by the Department of Scientific and Industrial Research, Government of India. The number of clinical studies conducted in India is rapidly growing across a range of therapy areas. The company's social responsibility programs focus on the development of underdeveloped villages, women, children, and age, specifically in the areas of healthcare and education. The GSK India product portfolio also includes prescription medicines and vaccines, and prescription medicines also range across therapeutic areas. It includes anti-infectives, dermatology, gynecology, diabetes, cardiovascular disease, oncology, and respiratory diseases. The GSK India is the market leader in the therapeutic categories in which it operates. GSK also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenza, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. The company's best–in–class field force, backed by a nationwide network of stockiest, ensures that the Company's products are readily available across the nation. The company also has 2 manufacturing units in India that are located at Nashik and Thane as well as a clinical development center in Bangalore. Also, the state of art plant at Nashik makes formulations while bulk drugs and the active pharmaceutical ingredients are manufactured at Thane.

Products:

Prescription medicines The GSK India product portfolio includes prescription medicines and vaccines and it is also a market leader in most of the prescription medicines such as:
  • Analgesic
  • Anti–Infective
  • Anti–Inflammatory
  • Anti–Parasitic
  • Cardiovascular
  • Dermatology
  • Diabetes
  • Endocrine
  • Gastrointestinal
  • Gynecology
  • Immunosuppressants
  • Nutritional
  • Respiratory
  • CNS
  • Oncology
 

Vaccines:

The company's vaccines division is one of the leaders in the fast-growing vaccine market. It provides vaccines for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenza, chickenpox, diphtheria, pertussis, tetanus, and others. Also, brands such as Engerix–B, Havrix, Priorix, and Twinrix are some vaccines that are created by GSK India. The company was awarded the “Multi-Cultural Diversity Award” from GlaxoSmithKline Consumer Healthcare, the US as an appreciation for the ‘Family Vaccines’ Programme. Also in 2008, the company launched two vaccines for diphtheria, tetanus and a cellular pertussis (DTP) namely Boostrix and Infanrix. The DTP vaccines are part of the routine immunization in over 100 developed as well as developing countries. The vaccine Infa